Orbia CEO Sameer Bharadwaj has for months been sounding out the possibilities for a sale of Netafim. The Mexican company is ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

Nvidia (NASDAQ: NVDA) has been one of the most successful stocks in the artificial intelligence (AI) arms race, rising 1,130% ...

If you are following Manhattan Associates, you might be asking yourself, "Is this the time to buy, hold or move on?" It is a fair question given how this stock has kept investors guessing lately.

Are you wondering what to do with Cognex stock after its recent moves? You are not alone. Investors are taking notice as ...

Palladyne AI Corp.'s technology is compelling, but the company is in an early commercialization stage. Read why PDYN stock is ...

Proprietary AI identifies off-market acquisition targets using firmographic and intent data—bringing institutional-grade sourcing to private ...

As inflation continues to erode purchasing power, investors are actively seeking asset allocation solutions that can preserve and grow wealth. Listed on the Toronto Stock ...

An economic envoy of Russian President Vladimir Putin has pitched the idea of building an underwater tunnel to link Russia ...

Asos shares knocked amid dispute over German import duties - The issue relates to customs declarations on Asos shipments ...

The global Cyclopentanone market is entering a period of sustained growth, with an estimated valuation of USD 369.3 million ...